BackRAMM Pharma Overview

RAMM Pharma Profit Margin

Latest profit margin for RAMM Pharma: -715.57% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-341.26%
↓ 476.22% YoY

As of Jul 2026

Annual Profit Margin (TTM)

-715.57%
↓ 104.16% YoY

Trailing 12 months ending Jul 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

RAMM Pharma (RAMM.CN) FAQ

RAMM Pharma (RAMM.CN) currently reports a profit margin of -715.57% as of July 2026. That compares with -350.49% in the prior-year period — down 104.2% year over year. That is below the sector sector average of 13.4%. Use the charts on this page to explore RAMM Pharma's profit margin history and peer comparisons.

RAMM Pharma's profit margin decreased from -350.49% to -715.57% — a 104.2% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RAMM Pharma's profit margin of -715.57% is lower than the its sector sector average of 13.4%. That is roughly 5438.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but RAMM Pharma's current -715.57% should be judged against industry norms (sector average: 13.4%) and against RAMM.CN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -715.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for RAMM Pharma, and consider following RAMM.CN for alerts when major investors trade the stock.